We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

260 hedge funds and large institutions have $3.09B invested in Axsome Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 26

28% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 75

7% more funds holding

Funds holding: 244 → 260 (+16)

1% less capital invested

Capital invested by funds: $3.12B → $3.09B (-$30.4M)

1.03% less ownership

Funds ownership: 82.88% → 81.84% (-1%)

25% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $66.4M

31% less funds holding in top 10

Funds holding in top 10: 13 → 9 (-4)

Holders
260
Holders Change
+16
Holders Change %
+6.56%
% of All Funds
3.75%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
45
Increased
96
Reduced
75
Closed
26
Calls
$49.5M
Puts
$66.4M
Net Calls
-$16.9M
Net Calls Change
-$54.8M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$56.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.7M
3
DTC
Deep Track Capital
Connecticut
+$25.6M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$23.5M
5
EAM
Eagle Asset Management
Florida
+$19M

Top Sellers

1
BI
BVF Inc
California
-$158M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$29.1M
4
TCM
Tang Capital Management
California
-$25.5M
5
Morgan Stanley
Morgan Stanley
New York
-$24.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Pictet Asset Management
26
Pictet Asset Management
Switzerland
$28.1M -$29.1M -346,566 -50%
EAM
27
Eventide Asset Management
Massachusetts
$27.7M – – –
FTM
28
First Turn Management
California
$27.3M +$3.92M +46,745 +16%
Northern Trust
29
Northern Trust
Illinois
$26.8M -$606K -7,223 -2%
JFG
30
Jefferies Financial Group
New York
$26.6M -$19.4M -230,569 -41%
Charles Schwab
31
Charles Schwab
California
$24M +$451K +5,373 +2%
Goldman Sachs
32
Goldman Sachs
New York
$23.3M +$7.2M +85,797 +42%
Loomis, Sayles & Company
33
Loomis, Sayles & Company
Massachusetts
$22.3M +$23.5M +279,791 New
Invesco
34
Invesco
Georgia
$19.6M +$16.7M +199,490 +432%
N
35
Nuveen
North Carolina
$19.6M +$913K +10,881 +5%
Barclays
36
Barclays
United Kingdom
$17.6M +$2.37M +28,236 +15%
EAM
37
Eagle Asset Management
Florida
$17.4M +$19M +226,515 New
GTC
38
Ghost Tree Capital
New York
$16.8M +$3.78M +45,000 +27%
DCM
39
Driehaus Capital Management
Illinois
$16.3M -$5.13M -61,143 -23%
Jane Street
40
Jane Street
New York
$15.9M +$8.92M +106,248 +114%
JP Morgan Chase
41
JP Morgan Chase
New York
$15.6M +$450K +5,356 +3%
Bank of America
42
Bank of America
North Carolina
$14.8M +$801K +9,546 +5%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$12.3M -$1.05M -12,522 -8%
RPAM
44
Rhenman & Partners Asset Management
Sweden
$11.5M +$5.41M +64,500 +82%
AAA
45
Affinity Asset Advisors
New York
$11.2M +$7.53M +89,758 +180%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
46
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$11M +$11.6M +138,300 New
ACM
47
Altium Capital Management
New York
$11M – – –
US Bancorp
48
US Bancorp
Minnesota
$10.7M -$833K -9,919 -7%
CC
49
Checkpoint Capital
California
$10.6M -$1.92M -22,909 -15%
IAM
50
Iridian Asset Management
Connecticut
$10.3M -$797K -9,495 -7%
1
2
3 4 5

AXSM Hedge Fund Activity: Q1 2024 in Review

260 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q1 2024, worth a combined $3.09B — down 0.98% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AXSM positions and 26 closed out — a net gain of 19 holders — while 96 added to existing stakes and 75 trimmed.

The largest buyer was Macquarie Group, adding an estimated $56.5M. The largest seller was BVF Inc, exiting entirely with an estimated $158M sold.

  • 260 institutional investors held Axsome Therapeutics (AXSM) as of Q1 2024, up from 244 in Q4 2023.
  • Funds reported $3.09B of Axsome Therapeutics stock for Q1 2024, down 0.98% quarter-over-quarter.
  • 45 funds opened new Axsome Therapeutics positions in Q1 2024 and 26 closed out, a net change of +19 holders.
  • The largest Axsome Therapeutics buyer in Q1 2024 was Macquarie Group, an estimated $56.5M added.
  • The largest Axsome Therapeutics seller in Q1 2024 was BVF Inc, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2024.